Resveratrol Reverses Functional Chagas Heart Disease in Mice.

Resveratrol Reverses Functional Chagas Heart Disease in Mice.

Chronic chagasic cardiomyopathy (CCC) develops years after acute infection by Trypanosoma cruzi and does not improve after trypanocidal therapy, despite reduction of parasite burden. During disease, the heart undergoes oxidative stress, a potential causative factor for arrhythmias and contractile dy...

Full description

Bibliographic Details
Main Authors:	Glaucia Vilar-Pereira, Vitor C Carneiro, Hilton Mata-Santos, Amanda R R Vicentino, Isalira P Ramos, Naira L L Giarola, Daniel F Feijó, José R Meyer-Fernandes, Heitor A Paula-Neto, Emiliano Medei, Marcelo T Bozza, Joseli Lannes-Vieira, Claudia N Paiva
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-10-01
Series:	PLoS Pathogens
Online Access:	https://doi.org/10.1371/journal.ppat.1005947

Similar Items

IL-1β is not critical to chronic heart dysfunction in mice with Chagas disease
by: Camila Victória Sousa Oliveira, et al.
Published: (2022-10-01)

Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease
by: Glaucia Vilar-Pereira, et al.
Published: (2015-12-01)

Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease
by: Yasmin Pedra-Rezende, et al.
Published: (2021-11-01)

Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease
by: Isabela Resende Pereira, et al.
Published: (2014-06-01)

CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy
by: Daniel Gibaldi, et al.
Published: (2020-03-01)

ROS and Trypanosoma cruzi: Fuel to infection, poison to the heart.
by: Claudia N Paiva, et al.
Published: (2018-04-01)

Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.
by: Glaucia Vilar-Pereira, et al.
Published: (2021-01-01)

Envolvimento de auto-anticorpos na fisiopatologia da Doença de Chagas Role of autoantibodies in the physiopathology of chagas' disease
by: Emiliano Horacio Medei, et al.
Published: (2008-10-01)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
by: Priscila Silva Grijó Farani, et al.
Published: (2021-07-01)

The centennial of the discovery of Chagas disease: facing the current challenges.
by: Joseli Lannes-Vieira, et al.
Published: (2010-01-01)

Genetic Ablation and Pharmacological Blockade of Bradykinin B1 Receptor Unveiled a Detrimental Role for the Kinin System in Chagas Disease Cardiomyopathy
by: Ana Carolina Oliveira, et al.
Published: (2023-04-01)

Resveratrol and Curcumin for Chagas Disease Treatment—A Systematic Review
by: Carlos Henrique Lima Imperador, et al.
Published: (2022-05-01)

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.
by: Roberto Rodrigues Ferreira, et al.
Published: (2019-07-01)

The presence of antiautonomic membrane receptor antibodies do not correlate with brain lesions in Chagas' disease A presença de anticorpos anti-autonômicos não se correlaciona a lesões cerebrais na doença de Chagas
by: Marco O. Py, et al.
Published: (2009-09-01)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
by: Priscila Silva Grijó Farani, et al.
Published: (2023-03-01)

Trypanosoma cruzi-elicited CD8+ T cell-mediated myocarditis: chemokine receptors and adhesion molecules as potential therapeutic targets to control chronic inflammation?
by: Joseli Lannes-Vieira
Published: (2003-04-01)

Chagas disease centennial anniversary celebration: historical overview and prospective proposals aiming to maintain vector control and improve patient prognosis - a permanent challenge
by: Joseli Lannes-Vieira, et al.
Published: (2009-07-01)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
by: Roberto Rodrigues Ferreira, et al.
Published: (2022-11-01)

Is there a role for extracellular matrix in thymus physiology and pathology?
by: Wilson Savino, et al.
Published: (1991-01-01)

Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease
by: Lindice Mitie Nisimura, et al.
Published: (2023-11-01)

Foreword
by: Ricardo Lourenço de Oliveira, et al.
Published: (2009-07-01)

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease
by: Julia T. Castro, et al.
Published: (2023-05-01)

Constitutive Accumulation of a Resveratrol-Glucoside in Transgenic Alfalfa Increases Resistance to Phoma medicaginis
by: John D. Hipskind, et al.
Published: (2000-05-01)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
by: Marilda Savoia Nascimento, et al.
Published: (2018-03-01)

Terapia celular na doença de Chagas Cell therapy in Chagas' disease
by: Ricardo S. Lima, et al.
Published: (2009-05-01)

Enfermedad de Chagas Chagas disease
by: Fernando Rosas A
Published: (2011-10-01)

Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues
by: Danielly C. Ferraz da Costa, et al.
Published: (2020-02-01)

Attitudes towards Chagas' disease in an endemic Brazilian community
by: Sarah Williams-Blangero, et al.

Attitudes towards Chagas' disease in an endemic Brazilian community
by: Williams-Blangero Sarah, et al.
Published: (1999-01-01)

Attitudes towards Chagas' disease in an endemic Brazilian community
by: Sarah Williams-Blangero, et al.

In vitro and in vivo experimental models for drug screening and development for Chagas disease
by: Alvaro José Romanha, et al.
Published: (2010-03-01)

Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from Brazil
by: Lucia Elena Alvarado-Arnez, et al.
Published: (2018-05-01)

Influence of Angiotensin-converting Enzyme Insertion/Deletion Gene Polymorphism in Progression of Chagas Heart Disease
by: Silvia Marinho Martins Alves, et al.
Published: (2020-07-01)

Disfunção autonômica e anticorpos contra receptores anti-m2 e anti-β1 em pacientes chagásicos Autonomic dysfunction and anti-M2 and anti-β1 receptor antibodies in Chagas disease patients
by: Clarissa Antunes Thiers, et al.
Published: (2012-08-01)

Anti-leishmanial effects of resveratrol and resveratrol nanoemulsion on Leishmania major
by: Parisa Mousavi, et al.
Published: (2022-02-01)

Surveillance of Chagas disease vectors in municipalities of the state of Ceará, Brazil
by: Teresa Cristina Monte Gonçalves, et al.
Published: (2009-12-01)

The Role of Resveratrol in Mammalian Reproduction
by: Rolando Pasquariello, et al.
Published: (2020-10-01)

American trypanosomiasis and Chagas disease: Sexual transmission
by: Clever Gomes, et al.
Published: (2019-04-01)

Esophageal striated muscle contractions in patients with Chagas' disease and idiopathic achalasia
by: R.O. Dantas, et al.
Published: (2002-06-01)

Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs
by: Mohamed Salla, et al.
Published: (2020-08-01)